Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02670057 · ClinicalTrials.gov registry record · NA
Sphenopalatine Ganglion Block to Treat Shoulder Pain During and/or After Cesarean
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 117
- Enrollment target
NCT02670057 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 117 participants.
The verdict
NCT02670057, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 117 participants
- Enrollment target
Study Summary
The purpose of this open label pilot study is to evaluate the utility of sphenopalatine ganglion (SPG) block to manage ipsilateral shoulder pain (ISP) during and/or after cesarean.
Interventions
- PROCEDURE Transnasal SPG block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2015-11 |
| Est. Completion | 2017-12-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02670057
The ClinicalTrials.gov registry entry for NCT02670057 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transnasal SPG block is the first listed.
NCT02670057 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02670057 about?
NCT02670057 is a clinical study titled "Sphenopalatine Ganglion Block to Treat Shoulder Pain During and/or After Cesarean". The purpose of this open label pilot study is to evaluate the utility of sphenopalatine ganglion (SPG) block to manage ipsilateral shoulder pain (ISP) during and/or after cesarean.
What is the current status of trial NCT02670057?
This trial is currently completed. It is a NA study. The enrollment target is 117 participants. The study started on 2015-11. Estimated completion is 2017-12-12.
What interventions are being tested in trial NCT02670057?
The interventions under investigation include: Transnasal SPG block (PROCEDURE).
Who is sponsoring clinical trial NCT02670057?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.